Integrated Diagnostics Holdings Stock Price Prediction

IDGXF Stock  USD 0.68  0.02  2.86%   
As of 29th of December 2025 The relative strength index (RSI) of Integrated Diagnostics' share price is above 80 . This usually indicates that the pink sheet is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 83

 Buy Peaked

 
Oversold
 
Overbought
The successful prediction of Integrated Diagnostics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Integrated Diagnostics and does not consider all of the tangible or intangible factors available from Integrated Diagnostics' fundamental data. We analyze noise-free headlines and recent hype associated with Integrated Diagnostics Holdings, which may create opportunities for some arbitrage if properly timed.
Using Integrated Diagnostics hype-based prediction, you can estimate the value of Integrated Diagnostics Holdings from the perspective of Integrated Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Integrated Diagnostics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Integrated because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Integrated Diagnostics after-hype prediction price

    
  USD 0.68  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Integrated Diagnostics Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Integrated Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.030.535.39
Details
Naive
Forecast
LowNextHigh
0.010.685.54
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.660.690.72
Details

Integrated Diagnostics After-Hype Price Prediction Density Analysis

As far as predicting the price of Integrated Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Integrated Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Integrated Diagnostics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Integrated Diagnostics Estimiated After-Hype Price Volatility

In the context of predicting Integrated Diagnostics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Integrated Diagnostics' historical news coverage. Integrated Diagnostics' after-hype downside and upside margins for the prediction period are 0.03 and 5.54, respectively. We have considered Integrated Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.68
0.68
After-hype Price
5.54
Upside
Integrated Diagnostics is out of control at this time. Analysis and calculation of next after-hype price of Integrated Diagnostics is based on 3 months time horizon.

Integrated Diagnostics Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Integrated Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Integrated Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Integrated Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.64 
4.86
 0.00  
  0.05 
0 Events / Month
2 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.68
0.68
0.00 
0.00  
Notes

Integrated Diagnostics Hype Timeline

Integrated Diagnostics is currently traded for 0.68. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.05. Integrated is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.64%. %. The volatility of related hype on Integrated Diagnostics is about 6352.94%, with the expected price after the next announcement by competition of 0.73. About 27.0% of the company shares are held by company insiders. The company last dividend was issued on the 8th of July 2021. Integrated Diagnostics had 4:1 split on the 24th of December 2020. Assuming the 90 days horizon the next anticipated press release will be uncertain.
Check out Integrated Diagnostics Basic Forecasting Models to cross-verify your projections.

Integrated Diagnostics Related Hype Analysis

Having access to credible news sources related to Integrated Diagnostics' direct competition is more important than ever and may enhance your ability to predict Integrated Diagnostics' future price movements. Getting to know how Integrated Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Integrated Diagnostics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ISPCiSpecimen 0.00 0 per month 0.00 (0.33) 9.09 (12.50) 28.46 
STRRStar Equity Holdings 0.00 0 per month 2.41 (0.02) 3.19 (4.67) 12.26 
BIAFbioAffinity Technologies,(0.23)7 per month 0.00 (0.13) 9.79 (13.78) 93.70 
APDNApplied DNA Sciences 0.00 0 per month 0.00  0.49  31.62 (8.69) 24.41 
SERASera Prognostics 0.00 0 per month 4.27  0.04  6.71 (6.67) 25.64 
PRPOPrecipio 1.95 11 per month 3.62  0.1  11.17 (7.23) 28.20 
GENEGenetic Technologies 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
MDXHMDxHealth SA ADR 0.00 0 per month 0.00 (0.13) 7.53 (6.55) 19.70 
STRRPStar Equity Holdings 0.00 0 per month 1.08 (0.07) 2.53 (1.89) 6.90 
LABStandard Biotools 0.10 4 per month 3.77  0.02  4.90 (6.30) 18.53 
GTHGenetron Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
BDSXBiodesix 0.00 0 per month 0.00 (0.02) 7.47 (9.22) 29.94 
NDRAENDRA Life Sciences 0.00 0 per month 7.65  0.02  13.24 (13.92) 49.07 
HTGMHTG Molecular Diagnostics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
INBSIntelligent Bio Solutions(0.20)9 per month 0.00 (0.25) 7.79 (10.53) 31.09 
BIAFWbioAffinity Technologies Warrant(0.09)3 per month 16.89  0.14  53.33 (35.00) 278.16 
SQLSeqLL Inc 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
IDXGInterpace Biosciences 0.00 0 per month 5.55  0.10  14.29 (10.45) 43.31 
STIMNeuronetics 0.00 0 per month 0.00 (0.16) 8.21 (9.09) 23.83 
PRPHProPhase Labs 0.00 0 per month 0.00 (0.34) 10.29 (17.95) 44.34 

Integrated Diagnostics Additional Predictive Modules

Most predictive techniques to examine Integrated price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Integrated using various technical indicators. When you analyze Integrated charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Integrated Diagnostics Predictive Indicators

The successful prediction of Integrated Diagnostics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Integrated Diagnostics Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Integrated Diagnostics based on analysis of Integrated Diagnostics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Integrated Diagnostics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Integrated Diagnostics's related companies.

Story Coverage note for Integrated Diagnostics

The number of cover stories for Integrated Diagnostics depends on current market conditions and Integrated Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Integrated Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Integrated Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Complementary Tools for Integrated Pink Sheet analysis

When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments